Abstract
Erectile dysfunction (ED) is a common condition in men; however, evidence of its association with mortality is limited. We examined the association between ED and long-term all-cause and cardiovascular (CV) mortality in a nationally representative cohort of adult men. This prospective cohort study included data from men aged 20 years and older from the 2001–2004 National Health and Nutrition Examination Survey linked to National Death Index records through December 31, 2019. ED was defined as reporting sometimes or never being able to achieve or maintain an erection adequate for satisfactory intercourse. Primary outcomes were the associations of ED with all-cause and CV mortality, evaluated using survey-weighted Cox proportional hazards regression models. Among 4 110 men followed for a median of 16.3 years, 1 226 deaths (419 CV deaths) occurred. In fully adjusted models, ED was independently associated with an increased risk of all-cause (HR, 1.45; 95% CI, 1.20–1.75) and CV (HR, 1.57; 95% CI, 1.12–2.19) mortality. The magnitude of these associations was similar to those observed for other CV risk factors such as diabetes mellitus, hypertension, and stroke. These findings suggest the need to broaden clinical perspectives on ED beyond sexual health to recognize its significance as a marker of mortality risk.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout




Similar content being viewed by others
Data availability
The data from this study will not be shared. Data from the 2001–2004 National Health and Nutrition Examination Survey (https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/default.aspx?BeginYear=2001; https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/default.aspx?BeginYear=2003) and National Death Index records through December 31, 2019 (https://www.cdc.gov/nchs/linked-data/mortality-files/index.html) are publicly available.
References
National Institutes of Health. NIH consensus conference. impotence. NIH consensus development panel on impotence. JAMA. 1993;270:83–90.
Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 1999;84:50–56.
Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U. Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’. Int J Impot Res. 2000;12:305–11.
Pinnock CB, Stapleton AM, Marshall VR. Erectile dysfunction in the community: a prevalence study. Med J Aust. 1999;171:353–7.
Nicolosi A, Glasser DB, Kim SC, Marumo K, Laumann EO. Group GI. sexual behaviour and dysfunction and help-seeking patterns in adults aged 40-80 years in the urban population of Asian countries. BJU Int. 2005;95:609–14.
Nicolosi A, Moreira ED Jr., Shirai M, Bin Mohd Tambi MI, Glasser DB. Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology. 2003;61:201–6.
Burnett AL, Nehra A, Breau RH, Culkin DJ, Faraday MM, Hakim LS, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200:633–41.
Elterman DS, Bhattacharyya SK, Mafilios M, Woodward E, Nitschelm K, Burnett AL. The quality of life and economic burden of erectile dysfunction. Res Rep Urol. 2021;13:79–86.
Banks E, Joshy G, Abhayaratna WP, Kritharides L, Macdonald PS, Korda RJ, et al. Erectile dysfunction severity as a risk marker for cardiovascular disease hospitalisation and all-cause mortality: a prospective cohort study. PLoS Med. 2013;10:e1001372.
Batty GD, Li Q, Czernichow S, Neal B, Zoungas S, Huxley R, et al. Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (action in diabetes and vascular disease: preterax and diamicron modified-release controlled evaluation) trial. J Am Coll Cardiol. 2010;56:1908–13.
Gazzaruso C, Solerte SB, Pujia A, Coppola A, Vezzoli M, Salvucci F, et al. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. J Am Coll Cardiol. 2008;51:2040–4.
Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA. Erectile dysfunction and subsequent cardiovascular disease. JAMA. 2005;294:2996–3002.
Montorsi P, Ravagnani PM, Galli S, Rotatori F, Briganti A, Salonia A, et al. The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease. Am J Cardiol. 2005;96:19M–23M.
Fan Y, Hu B, Man C, Cui F. Erectile dysfunction and risk of cardiovascular and all-cause mortality in the general population: a meta-analysis of cohort studies. World J Urol. 2018;36:1681–9.
Vlachopoulos CV, Terentes-Printzios DG, Ioakeimidis NK, Aznaouridis KA, Stefanadis CI. Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies. Circ Cardiovasc Qual Outcomes. 2013;6:99–109.
Loprinzi PD, Nooe A. Erectile dysfunction and mortality in a national prospective cohort study. J Sex Med. 2015;12:2130–3.
Selvin E, Wang D, Tang O, Fang M, Christenson RH, McEvoy JW. Elevated cardiac biomarkers, erectile dysfunction, and mortality in U.S. Men: NHANES 2001–2004. JACC Adv. 2023;2:100380.
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453–7.
Centers for Disease Control and Prevention. About NHANES.2024. https://www.cdc.gov/nchs/nhanes/about/. Accessed date: October 18, 2024.
O’Donnell AB, Araujo AB, Goldstein I, McKinlay JB. The validity of a single-question self-report of erectile dysfunction. results from the massachusetts male aging study. J Gen Intern Med. 2005;20:515–9.
Centers for Disease Control and Prevention. Public-use linked mortality files. 2024. https://ftp.cdc.gov/pub/Health_Statistics/NCHS/datalinkage/linked_mortality/. Accessed date: October 18, 2024.
Centers for Disease Control and Prevention. The linkage of National Center for Health Statistics survey data to the National Death Index – 2019 Linked Mortality File (LMF): Linkage methodology and analytic considerations. 2024. https://www.cdc.gov/nchs/data/datalinkage/2019NDI-Linkage-Methods-and-Analytic-Considerations-508.pdf. Accessed date: October 18, 2024.
De Leonardis F, Colalillo G, Finazzi Agro E, Miano R, Fuschi A, Asimakopoulos AD. endothelial dysfunction, erectile deficit and cardiovascular disease: an overview of the pathogenetic links. Biomedicines. 2022;10:1848.
Osondu CU, Vo B, Oni ET, Blaha MJ, Veledar E, Feldman T, et al. The relationship of erectile dysfunction and subclinical cardiovascular disease: A systematic review and meta-analysis. Vasc Med. 2018;23:9–20.
Allen MS, Wood AM, Sheffield D. The psychology of erectile dysfunction. Curr Directions Psychological Sci. 2023;32:487–93.
Rasmussen S, Balasubramaniam K, Jarbol DE, Sondergaard J, Haastrup PF. Socioeconomic status and barriers for contacting the general practitioner when bothered by erectile dysfunction: a population-based cross-sectional study. BMC Fam Pract. 2020;21:166.
Antonio L, Wu FCW, Moors H, Mathei C, Huhtaniemi IT, Rastrelli G, et al. Erectile dysfunction predicts mortality in middle-aged and older men independent of their sex steroid status. Age Ageing. 2022;51:afac094.
Araujo AB, Travison TG, Ganz P, Chiu GR, Kupelian V, Rosen RC, et al. Erectile dysfunction and mortality. J Sex Med. 2009;6:2445–54.
Chew KK, Gibson N, Sanfilippo F, Stuckey B, Bremner A. Cardiovascular mortality in men with erectile dysfunction: increased risk but not inevitable. J Sex Med. 2011;8:1761–71.
Chung RY, Chan D, Woo J, Kwok T, Leung JC, Lai FT, et al. Erectile dysfunction is associated with subsequent cardiovascular and respiratory mortality in cohort of 1436 Chinese elderly men. J Sex Med. 2015;12:1568–76.
Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:e596–e646.
US Department of Health and Human Services. Healthy People 2030: Browse objectives by topic. 2025. https://odphp.health.gov/healthypeople/objectives-and-data/browse-objectives. Accessed date: March 20, 2025.
Horasanli K, Boylu U, Kendirci M, Miroglu C. Do lifestyle changes work for improving erectile dysfunction? Asian J Androl. 2008;10:28–35.
Ebner B, Ebner A, Reetz A, Bohme S, Schauer A, Strasser RH, et al. Pharmacological postconditioning by bolus injection of phosphodiesterase-5 inhibitors vardenafil and sildenafil. Mol Cell Biochem. 2013;379:43–49.
Ockaili R, Salloum F, Hawkins J, Kukreja RC. Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits. Am J Physiol Heart Circ Physiol. 2002;283:H1263–1269.
Sesti C, Florio V, Johnson EG, Kloner RA. The phosphodiesterase-5 inhibitor tadalafil reduces myocardial infarct size. Int J Impot Res. 2007;19:55–61.
Salloum FN, Chau VQ, Hoke NN, Kukreja RC. Tadalafil prevents acute heart failure with reduced ejection fraction in mice. Cardiovasc Drugs Ther. 2014;28:493–500.
Andersson DP, Trolle Lagerros Y, Grotta A, Bellocco R, Lehtihet M, Holzmann MJ. Association between treatment for erectile dysfunction and death or cardiovascular outcomes after myocardial infarction. Heart. 2017;103:1264–70.
Soulaidopoulos S, Terentes-Printzios D, Ioakeimidis N, Tsioufis KP, Vlachopoulos C. Long-term effects of phosphodiesterase-5 inhibitors on cardiovascular outcomes and death: a systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2024;10:403–12.
Andersson DP, Landucci L, Lagerros YT, Grotta A, Bellocco R, Lehtihet M, et al. Association of phosphodiesterase-5 inhibitors versus alprostadil with survival in men with coronary artery disease. J Am Coll Cardiol. 2021;77:1535–50.
Jehle DVK, Sunesra R, Uddin H, Paul KK, Joglar AA, Michler OD, et al. Benefits of tadalafil and sildenafil on mortality, cardiovascular disease, and dementia. Am J Med. 2025;138:441–8.e443.
Baldwin K, Ginsberg P, Harkaway RC. Under-reporting of erectile dysfunction among men with unrelated urologic conditions. Int J Impot Res. 2003;15:87–89.
Funding
Boston Scientific supported this study. The sponsor was involved in the study design, interpretation of the data, review and approval of the manuscript, and decision to submit the manuscript for publication. The sponsor was not involved in the analysis of the data or drafting of the manuscript.
Author information
Authors and Affiliations
Contributions
L.M. conducted the analysis and drafted the manuscript. S.B., S.R., and D.P. critically reviewed and edited the manuscript. S.B. supervised the project administration. All authors reviewed and approved the final version of the manuscript. L.M. had primary responsibility for the final content.
Corresponding author
Ethics declarations
Competing interests
S.B. and S.R. report employment with Boston Scientific. L.M. reports consultancy with Boston Scientific. D.P. reports receiving a grant from the Biomedical Laboratory Research & Development Service (BLRD) of the US Department of Veterans Affairs, unrelated to this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Bhattacharyya, S., Miller, L.E., Rojanasarot, S. et al. Association of erectile dysfunction with all-cause and cardiovascular mortality in US men: findings from NHANES 2001–2004 with 16-year follow-up. Int J Impot Res (2025). https://doi.org/10.1038/s41443-025-01218-z
Received:
Revised:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41443-025-01218-z


